“06 | Nirsevimab As a Key Strategy to Prevent Respiratory Syncytial Virus Among Newborns and Children: Real-World Evidence from Italy and Sicily”. EuroMediterranean Biomedical Journal 21, no. s1 (November 10, 2026). Accessed November 12, 2026. https://www.embj.org/home/article/view/671.